{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:55:22Z","timestamp":1792587322195,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>To counteract the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented globally, exerting a profound influence on a wide spectrum of infectious diseases, encompassing respiratory tract infections (RTIs). Subsequent to the easing of NPIs, China experienced a significant outbreak of <jats:italic>Mycoplasma pneumoniae<\/jats:italic> (MP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Over a decade from 2015 to 2024, our study scrutinized 12 common infectious diseases among pediatric children. Etiologically diagnostic data and clinical outcome metrics of children with RTIs, tested for 13 pathogens, were analyzed to evaluate changes during and after the pandemic compared to pre-pandemic periods, with a notable emphasis on age profile and coinfection patterns of MP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 57,471 hospitalized children, 23,178 were diagnosed with infectious diseases. Under NPIs, most respiratory infections declined compared to pre-pandemic levels, rebounding by 69.64% in 2023. While the infection rate of common respiratory pathogens decreased, cases of respiratory syncytial virus increased during the period of extensive NPI implementation. In 2023, pediatric intensive care unit durations for these pathogens increased, suggesting greater severity of illness compared to 2019. MP exhibited the highest infection rate (31.38% average), with a notable outbreak post-pandemic due to severity increase in &amp;lt;3\u2009year olds and rise among older children. NPIs reduced MP coinfections and mitigated their severity, while exerting a significant influence on bacterial coinfections with MP over the span of 5\u2009years, in contrast to their impact on viral pathogens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NPIs effectively curb transmission of respiratory infections by most pathogens, resulting in increased average age of MP infections and altered patterns of coinfection post-pandemic.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1437508","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:28:12Z","timestamp":1728448092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Respiratory pathogen analysis in pediatric inpatients unraveled the infection pattern of Mycoplasma pneumoniae post the COVID-19 pandemic"],"prefix":"10.3389","volume":"12","author":[{"given":"Qihong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanshan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2021.07.005","article-title":"Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19","volume":"110","author":"Kim","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e13103","DOI":"10.1111\/irv.13103","article-title":"Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID-19 pandemic in Central China","volume":"17","author":"Ren","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41551-020-00633-5","article-title":"Open resource of clinical data from patients with pneumonia for the prediction of COVID-19 outcomes via deep learning","volume":"4","author":"Ning","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12985-020-01475-y","article-title":"Epidemiological characteristics of four common respiratory viral infections in children","volume":"18","author":"Zhu","year":"2021","journal-title":"Virol J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1473-3099(01)00170-0","article-title":"Estimates of world-wide distribution of child deaths from acute respiratory infections","volume":"2","author":"Williams","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1093\/cid\/ciab942","article-title":"Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study","volume":"75","author":"Li","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1017\/S0950268819000839","article-title":"The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016","volume":"147","author":"Gao","year":"2019","journal-title":"Epidemiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae surveillance (MAPS) study group. Mycoplasma pneumoniae: Delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Meyer Sauteur","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","article-title":"Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-023-00793-9","article-title":"Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen","volume":"20","author":"Zhang","year":"2024","journal-title":"World J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15585\/mmwr.mm7307a3","article-title":"Notes from the field: reemergence of Mycoplasma pneumoniae infections in children and adolescents after the COVID-19 pandemic, United States, 2018-2024","volume":"73","author":"Edens","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","article-title":"Current status of Mycoplasma pneumoniae infection in China","volume":"20","author":"Yan","year":"2024","journal-title":"World J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jinf.2021.01.009","article-title":"Coinfection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features","volume":"82","author":"De Francesco","year":"2021","journal-title":"J Inf Secur"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e20200961","DOI":"10.1542\/peds.2020-0961","article-title":"Coinfection and other clinical characteristics of COVID-19 in children","volume":"146","author":"Wu","year":"2020","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1337786","DOI":"10.3389\/fped.2024.1337786","article-title":"Adenovirus and Mycoplasma pneumoniae coinfection as a risk factor for severe community-acquired pneumonia in children","volume":"12","author":"Chen","year":"2024","journal-title":"Front Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/antibiotics12111623","article-title":"Characteristics of the Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide resistance and coinfection trends","volume":"12","author":"Shin","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.3346\/jkms.2023.38.e311","article-title":"Impact of nonpharmacological interventions on severe acute respiratory infections in children: from the National Surveillance Database","volume":"38","author":"Yoon","year":"2023","journal-title":"J Korean Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.15585\/mmwr.mm7029a1","article-title":"Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021","volume":"70","author":"Olsen","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.prrv.2021.04.003","article-title":"Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses","volume":"39","author":"Chiapinotto","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(22)00525-4","article-title":"Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study","volume":"23","author":"Bardsley","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/ppul.25582","article-title":"During the COVID-19 pandemic where has respiratory syncytial virus gone?","volume":"56","author":"di Mattia","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00430-021-00720-7","article-title":"Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing","volume":"210","author":"Stamm","year":"2021","journal-title":"Med Microbiol Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.2147\/IDR.S388231","article-title":"Epidemiological trend of RSV infection before and during COVID-19 pandemic: a three-year consecutive study in China","volume":"15","author":"Qiu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00705-023-05891-7","article-title":"The changing pattern of common respiratory viruses among children from 2018 to 2021 in Wuhan, China","volume":"168","author":"Wan","year":"2023","journal-title":"Arch Virol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1216536","DOI":"10.3389\/fcimb.2023.1216536","article-title":"Are we ready to face the next wave of RSV surge after the COVID-19 omicron pandemic in China?","volume":"13","author":"Jiang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00284-022-03103-0","article-title":"Insight into the pathogenic mechanism of Mycoplasma pneumoniae","volume":"80","author":"Hu","year":"2022","journal-title":"Curr Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.ijmmb.2023.100480","article-title":"Mycoplasma pneumoniae: among the smallest bacterial pathogens with great clinical significance in children","volume":"46","author":"Kumar","year":"2023","journal-title":"Indian J Med Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2666-5247(22)00190-2","article-title":"ESGMAC and the ESGMAC\u2013MyCOVID study group. Mycoplasma pneumoniae Beyond the COVID-19 pandemic: where is it?","volume":"3","author":"Sauteur","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jinf.2022.12.030","article-title":"Changes of Mycoplasma pneumoniae prevalence in children before and after COVID-19 pandemic in Henan, China","volume":"86","author":"Li","year":"2023","journal-title":"J Inf Secur"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"854505","DOI":"10.3389\/fcimb.2022.854505","article-title":"The prevalence of Mycoplasma Pneumoniae among children in Beijing before and during the COVID-19 pandemic","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref32","first-page":"00406","article-title":"Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae","author":"Meyer Sauteur","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","article-title":"Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and Meta-analysis","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/idr13030073","article-title":"Update on the epidemiology of macrolide-resistant Mycoplasma pneumoniae in Europe: a systematic review","volume":"13","author":"Loconsole","year":"2021","journal-title":"Infect Dis Rep"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/jcm11071782","article-title":"Recent trends in the epidemiology, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae","volume":"11","author":"Oishi","year":"2022","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.idnow.2022.12.003","article-title":"Immune debt: recrudescence of disease and confirmation of a contested concept","volume":"53","author":"Cohen","year":"2023","journal-title":"Infect Dis Now"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.puhe.2023.12.009","article-title":"Postpandemic immunity debt of influenza in the USA and England: an interrupted time series study","volume":"227","author":"Leung","year":"2024","journal-title":"Public Health"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.5582\/bst.2023.01303","article-title":"Immunity debt: hospitals need to be prepared in advance for multiple respiratory diseases that tend to co-occur","volume":"17","author":"Li","year":"2024","journal-title":"Biosci Trends"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.7150\/thno.61832","article-title":"Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"100497","DOI":"10.1016\/j.lanepe.2022.100497","article-title":"Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: a prospective multicentric surveillance study in France","volume":"22","author":"Cohen","year":"2022","journal-title":"Lancet Reg Health Eur"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1437508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:28:16Z","timestamp":1728448096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1437508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":40,"alternative-id":["10.3389\/fpubh.2024.1437508"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1437508","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"article-number":"1437508"}}